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Abstract 31 
 Spiralin is the most abundant protein of several species of spiroplasmas, helical, 32 
motile bacteria pathogenic for arthropods and plants. This amphiphilic protein is anchored to 33 
the outer face of the plasma membrane by a lipoylated N-terminal cysteine. Although 34 
spiroplasma pathogenicity in mammals is controversial, it was shown that spiralin is highly 35 
immunogenic and endowed with immunomodulatory activity. In this paper, we describe a 36 
high performance method for the purification of Spiroplasma melliferum spiralin under non-37 
denaturing conditions. The protein was selectively extracted with 3-[(3-cholamidopropyl) 38 
dimethylammonio]-1-propyl sulfonate (CHAPS) from the membrane pre-treated with sodium 39 
dodecyl-N-sarcosinate (Sarkosyl), and purified to homogeneity by cation-exchange HPLC 40 
with an overall yield of ~ 60%. Detergent-depleted, water-soluble micelles of spiralin 41 
displaying a mean diameter of 170 Å, as evidenced by transmission electron microscopy, 42 
were obtained by dialysis detergent removal. Circular dichroism spectroscopy and cross 43 
immunoprecipitation assay of the purified spiralin strongly suggested that this purification 44 
method could retain the structural characteristics of the native spiralin. The strategy 45 
developed to purify spiralin (two successive selective extractions of membrane proteins with 46 
mild detergents followed by ion-exchange chromatography) should prove useful for the 47 
purification of membrane lipoproteins of other bacteria of the class Mollicutes including 48 
different pathogens for humans, animals and plants. 49 
 50 
Highlights 51 
- An improved procedure for the purification of a bacterial lipoprotein is presented. 52 
- The new procedure shortens the purification from 24 hours to 4 hours. 53 
- Detergent screening revealed that spiralin is mostly insoluble in Sarkosyl and Triton X-100.  54 
- Milligram quantities of highly pure spiralin can be obtained. 55 
- The procedure is non-denaturing. 56 
 57 
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1. Introduction 66 
 Bacterial membrane lipoproteins are bound to the lipid bilayer by a di- or a tri-fatty-67 
acylated N-terminal cysteine [for a recent review: [1] ]. This covalent modification occurs in 68 
proteins belonging to different families acting as cell receptors, enzymes, transporters, or 69 
adhesins. Some of them, such as E. coli Braun’s lipoprotein have also a structural function [2-70 
4]. In host-bacteria interactions, the lipidic moiety of lipoproteins modulate the activity of the 71 
vertebrate immune system through binding to host Toll-like receptors [5]. Some lipoproteins 72 
further display antigen variability within their polypeptide chain enabling the pathogen to 73 
evade the host immune defenses [6]. In Mollicutes, murein-less bacteria including 74 
Mycoplasma spp. and Spiroplasma spp., lipoproteins are tightly anchored to the external 75 
leaflet of the plasma membrane and face the host environment. A large number of 76 
mycoplasmal lipoproteins have been associated to bacterial cytadherence [7], to phase, size, 77 
and antigenic variation [8], or to immunomodulatory effects [9-11]. Spiralin is the major 78 
membrane lipoprotein of a certain number of Spiroplasma species infecting plants and 79 
arthropods. This lipoprotein was first discovered in Spiroplasma citri [12] and later in S. 80 
melliferum [13], S. kunkelii, and S. phoeniceum [14]. Spiralin is one of the most well-studied 81 
Mollicute lipoproteins as evidenced by the large range of structural, expression and functional 82 
data available [15-20]. Spiralin purified from S. melliferum membrane possesses 83 
immunostimulating activity on human peripheral blood mononuclear cells and murine 84 
splenocytes [16]. In the phytopathogenic S. citri, spiralin is essential for an efficient 85 
transmission of the bacteria to the plant host by the insect vector [18], is involved in the 86 
invasion of the insect cells, and exhibits glycoconjugate binding properties [21]. In addition, 87 
given the high abundance of the protein, which is located exclusively on the outer leaflet of 88 
the bacterial membrane, a mechanical function for spiralin has been proposed in addition to 89 
its putative role as a lectin. However, structural information that could help understanding the 90 
function of spiralin is still missing. For instance, no information on the tertiary structure of 91 
spiralin is available to date. Similarly, no thorough mass spectrometry analysis of the protein 92 
to elucidate whether spiralin is a target of unidentified posttranslational modifications as 93 
proposed before [22] has been conducted.  94 
Valuable information about the function of spiralin could thus be obtained from 95 
structural studies. However, the availability of efficient purification procedures is still 96 
nowadays the bottleneck of lipoprotein studies. The general strategy of recombinant 97 
technology consisting of overproducing the protein in a genetically modified host cell has 98 
allowed the purification of a large number of proteins. However, in the case of Mollicutes 99 
lipoproteins, many difficulties may be encountered when using the recombinant methodology. 100 
The solubilization of the overproduced amphiphilic protein may prove difficult without loss 101 
of the native structure. The host cell may also fail to perform the covalent modifications of the 102 
naturally produced protein. Incorrect interpretation of the membrane targeting signals and/or 103 
toxicity due to the accumulation of the foreign protein in the cell membrane(s) may occur. 104 
In the case of S. citri spiralin, a recombinant protein could be expressed in E. coli [23]. 105 
However, the recombinant product proved to be localized not only in the inner membrane but 106 
also in the outer membrane and cytoplasm of E. coli [24]. In addition, the recombinant 107 
spiralin did not appear to be correctly post-translationally modified as three forms differing in 108 
their apparent molecular mass could be detected in E. coli, and not in S. citri [24]. In the past, 109 
we developed different strategies to purify spiralin [12,17,20]. Starting from S. citri 110 
membranes, the purification process of the native spiralin entailed essentially three steps: (1) 111 
removal of extrinsic proteins using Tween 20 or Sarkosyl, (2) selective extraction of spiralin 112 
with 0.2 M sodium deoxycholate (DOC) or 100 mM CHAPS, and (3) fractionation of the 113 
DOC/CHAPS-soluble material by preparative agarose-suspension electrophoresis (ASE). 114 
However, this protocol is time-consuming and the amount of protein obtained is limited to 1 115 
mg per separation. Moreover, the different steps were empirically designed. In this work, we 116 
aimed at optimizing the spiralin purification protocol by screening a variety of detergents for 117 
the initial extraction step, and establishing a cation exchange chromatography for the final 118 
purification. We could thereby shorten the total duration of the process and the final 119 
separation step offered a higher adaptability to amount of available starting material.  120 
 121 
2. Materials and methods 122 
2.1. Reagents 123 
Acrylamide and N,N’-methylene bisacrylamide were from BDH (U. K.). Agarose (Indubiose 124 
A37) was from IBF (France). HECAMEG, N-dodecyl-N,N-dimethyl-3-ammonio-1-propane 125 
sulfonate (SB-12, lauryl sulfobetaine), N-tetradecyl-N,N-dimethyl-3-ammonio-1-propane 126 
sulfonate (SB-14, tetradecyl sulfobetaine), 3-[(3-cholamidopropyl) dimethylammonio]-1-127 
propyl sulfonate (CHAPS), N-octyl-ß-D-glucopyranoside (OG), : nonaethyleneglycol 128 
octylphenol ether (Triton X-100) and sodium lauroyl-N-sarcosinate (Sarkosyl) were obtained 129 
from Sigma (U.S.A.). Sodium cholate and sodium deoxycholate (DOC) were from 130 
Calbiochem (La Jolla, California, U. S. A.). Sodium dodecylsulfate (SDS) was from Merck 131 
(Germany).  N-dodecyl-N,N-dimethylammonio butyrate (DDMAB) and N-dodecyl-N,N-132 
dimethylammonio undecanoate (DDMAU) were generous gifts from Y. Chevalier (CNRS 133 
UPR 9031, Vernaison, France). Cholylsarcosine was a generous gift from Diamalt (München, 134 
Germany). N-octanoyl-beta-D-glucosylamine (NOGA) was synthesized through the 135 
procedure described in Brenner-Henaff et al. (1993). 136 
 137 
2.2. Protein concentration determination  138 
Protein concentration was determined with the method of Lowry et al. [25] modified by 139 
Markwell et al. [26], using bovine serum albumin as standard. Titration of individual proteins 140 
was performed by scanning densitometry after SDS-PAGE and Coomassie brilliant blue R250 141 
staining. 142 
 143 
2.3. Preparation of S. melliferum membranes 144 
S. melliferum (strain BC-3T, ATCC 33219) [27] was grown under microaerobic 145 
conditions as previously described [28]. Cells were harvested by centrifugation at 10,000g for 146 
15 min and washed once in 50 mM sodium phosphate buffer containing 150 mM NaCl and 147 
550 mM D(-)sorbitol. The cells were then dispersed in 50 mM Tris-HCl buffer (pH 8.0) 148 
containing 1 mM of 4-(2-aminoethyl)-benzene sulfonyl fluoride (protease inhibitor, AEBSF) 149 
and disrupted by sonication (2 x 30 sec) with 500-Watt Ultrasonic Processor equipped with a 150 
titanium-tapered microtip. Plasma membranes were centrifuged three times 1 h at 38,000g in 151 
50 mM Tris-HCl buffer pH 8.0 to remove cytoplasmic components. They were dispersed and 152 
stirred overnight in 5 mM Tris-HCl buffer (pH 8.0) containing 5 mM EDTA and 1 mM DTT. 153 
They were finally centrifuged at 38,000g and dispersed in 10 mM HEPES buffer (pH 7.4). All 154 
the operations were performed at 0-4°C and 5 ml membrane suspensions containing 10 mg 155 
protein ml-1 were stored at –80°C until use.   156 
 157 
2.4. Membrane protein extraction with detergents 158 
Proteins were extracted with detergents by mixing one volume of membrane suspension 159 
(10 mg of protein per ml of 100 M Na phosphate buffer, pH 7.5) with one volume of 160 
detergent solubilized in water. After 1 h with intermittent shaking, the mixture was 161 
centrifuged at 260,000g for 15 min (Beckman TL-100 ultracentrifuge, TLA 100.1 rotor) to 162 
separate solubilized proteins from insoluble material. Operations were performed at 18°C 163 
when SDS was used and at 4°C in the case of other detergents. 164 
 165 
2.5. Preparation of antibodies 166 
Antibodies against S. melliferum membrane proteins were elicited in three rabbits by 167 
subcutaneous inoculation, twice a month, of isolated membranes. Each inoculum was 168 
composed of 1 mg of membrane protein in 0.5 ml of 150 mM NaCl and emulsified with 0.7 169 
ml of Freund adjuvant. The latter was used complete only for the first inoculation. After 3 170 
months of immunization, the rabbits were bled and the three sera were pooled. The same 171 
procedure was used to obtain the antibodies which can recognize spiralin specifically. In that 172 
case, the immunogen was composed of 10 µg of pure spiralin detergent-free micelles per 173 
inoculum. 174 
 175 
2.6. Chromatographic techniques 176 
Preparative protein separations were performed by cation exchange chromatography in 177 
a column of methacrylate co-polymer resin beads covalently bonded with propylsulfonic acid 178 
functionalities (Waters Protein Pack SP8HR: resin particle diameter, 8 µm; pore size, 0.1 µm; 179 
column internal diameter, 1 cm; column length, 10 cm) and a Waters 625 HPLC system. The 180 
samples contained membrane proteins solubilized with 100 mM CHAPS in 20 mM sodium 181 
citrate buffer (pH 4.5) containing 4 mM DTT. Elution of the proteins adsorbed on the column 182 
was performed with a salt concentration gradient using the following buffers: 20 mM sodium 183 
citrate buffer (pH 4.5) containing 16 mM CHAPS and 2 mM DTT (Buffer A) and buffer A 184 
containing 1 M NaCl (Buffer B). Elution conditions (1 ml min-1): 0 to 5 min, 100% buffer A; 185 
5 to 40 min, linear gradient to 30% buffer B; 40 to 50 min, 30% buffer B; 50 to 60 min, linear 186 
gradient up to 100% buffer B; 60 to 75 min, 100% buffer B, and 75 to 80 min, linear gradient 187 
down to 0% buffer B. The eluates were monitored by light absorbance at 280 nm and 188 
fractions were analyzed by SDS-PAGE. 189 
The homogeneity of spiralin detergent-free micelles was analyzed by size-exclusion 190 
HPLC (SEC) in a Superdex 200 HR column (diameter, 1 cm; height, 30 cm) (Pharmacia, 191 
Uppsala, Sweden). The buffer used for column equilibration and protein elution (0.4 ml min-1) 192 
was 50 mM sodium phosphate buffer pH 7.0 containing 150 mM NaCl. Spiralin and reference 193 
proteins (thyroglobulin, ferritin, catalase, apotransferrin, hemoglobin and cytochrome c) were 194 
detected by light absorption at 280 nm. 195 
 196 
2.7. Preparation of spiralin detergent-depleted micelles 197 
Detergent was removed using the Lipoprep® (Dianorm) flow-through dialyzer [29]. The 198 
central compartment of the Teflon cell was loaded with 8 ml of a solution of spiralin (2 mg 199 
protein per ml of 10 mM sodium phosphate buffer) containing 16 mM CHAPS. Dialysis was 200 
performed for 36 h at 6°C through two cellulose membranes (diameter, 5 cm; cut-off, 10 201 
kDa). The solution was stirred with a magnet spinning at 60 rev. min-1 and the dialysis buffer 202 
(10 mM sodium phosphate buffer, pH 7.2) was pumped through the two side compartments at 203 
a flow rate of 5 ml min-1. 204 
 205 
2.8. SDS-PAGE 206 
Protein extracts were diluted 1:10 in loading buffer (62.5 mM Tris-HCl pH 6.8, 20 mM 207 
DTT, 2% SDS, 40% glycerol, and 0.01% bromophenol blue). The proteins were separated in 208 
120 x 120 x 1 mm polyacrylamide gels in the presence of 0.1% SDS with the method of 209 
Laemmli [30]. Compositions of the stacking and separating gels were T = 4.8%, C = 2.6% 210 
and T = 10%, C = 2.6%, respectively, with %T being the total monomer (acrylamide + 211 
bisacrylamide) concentration and %C the percentage of bisacrylamide relative to total 212 
monomer. Proteins were silver stained according to the method of Tunón and Johansson [31].  213 
 214 
2.9. Immunoelectrophoresis 215 
Crossed immunoelectrophoresis [32] was performed as described previously [33], in the 216 
presence of 10 mM SB12 to avoid the precipitation of hydrophobic proteins. Antibodies 217 
against S. melliferum membranes were prepared as described above and the serum was used at 218 
a 1/20 dilution. The directions of migration are indicated on Figure 7. After electrophoresis, 219 
the gels were washed and dried, and the immunoprecipitates were stained with Coomassie 220 
brilliant blue R-250. 221 
Fused-rocket immunoelectrophoresis was performed as described previously [12], using 222 
antibodies directed against S. melliferum membrane similarly to the crossed 223 
immunoelectrophoresis. 224 
 225 
2.10. Circular dichroism spectroscopy 226 
 Circular dichroism spectra of spiralin were recorded from 190 to 260 nm at 20°C on a 227 
Jasco 810 (Jasco, Bouguenais, France) spectropolarimeter equipped with a thermostatically 228 
controlled quartz cell with a path length of 2 mm. Spectra were required at a step resolution of 229 
0.1 nm and at a 50 nm min-1 speed (bandwidth: 1 nm). The sample was prepared in 10 mM 230 
sodium phosphate buffer pH 7.4 at a final protein concentration of 3.8 µM. When needed, 50 231 
mM CHAPS or 35 mM SDS was included in the samples. For each analysis three scans were 232 
performed and subsequently averaged. Corrections were made for buffer contribution.  233 
 Spectrum deconvolution was performed using the CDPro package. The ContinLL 234 
method was chosen to estimate secondary structure of spiralin. Wavelengths from 190 to 240 235 
nm were submitted for analysis and the SMP56 reference set was chosen [34]. 236 
 237 
2.11. Transmission electron microscopy 238 
 Suspensions of detergent-free spiralin micelles (0.02 mg ml-1 of 50 mM sodium 239 
phosphate buffer pH 7.4) were deposited on glow-discharged carbon-coated 200-mesh copper 240 
grids. After one min of contact, the adsorbed micelles were washed three times with distilled 241 
water and negatively contrasted with 2% uranyl acetate. Micrographs were taken with a 242 
Philips CM12 microscope operating at 120 kV and at a magnification of x 45,000.  243 
 244 
3. Results and Discussion 245 
3.1. Selective extraction of spiralin from the spiroplasma membrane 246 
Selective extraction of membrane proteins by detergents has proven to be a very 247 
powerful tool to purify proteins [35,36]. Spiralin can be extracted from spiroplasma 248 
membranes by sequential action of detergents [12]. In the original protocol describing the 249 
purification of spiralin, Tween 20 was used to deplete the whole membranes from proteins 250 
leaving most of the spiralin in the insoluble fraction. Then, spiralin was solubilized by DOC, 251 
which selectively extracted this protein. Later, Sarkosyl was used in place of Tween 20 to 252 
reduce the time required for the extraction, and DOC was replaced by CHAPS [20]. There 253 
was no rationale behind the choice of these detergents except that they are non-denaturing 254 
detergents. We then decided to screen for other detergents which would have low selectivity 255 
for spiralin and could be used to deplete non-spiralin proteins from the membranes. 256 
Fifteen non-denaturing detergents were compared for their ability to extract spiralin from the 257 
plasma membrane of S. melliferum. In each case, the amount of spiralin vs. total protein 258 
extracted was determined as a function of detergent concentration. Fig. 1 illustrates the results 259 
obtained with cholylsarcosine, CHAPS, and Sarkosyl, and Table 1 recapitulates the data 260 
obtained with the whole series of detergents. Most of the detergents extracted spiralin 261 
efficiently and selectively except for Triton X-100 and Sarkosyl. Triton X-100 could extract 262 
only 20% of proteins from the membrane and provide low amounts of spiralin. On the other 263 
hand, Sarkosyl could extract more proteins and had less selectivity for spiralin than Triton X-264 
100. Sarkosyl at concentrations ≥ 50 mM extracted 55% of total protein but only 15% of 265 
spiralin (Fig. 1A & 1B). Among the alkylated ionic detergents, Sarkosyl had the unique 266 
property of being unable to efficiently extract spiralin from the plasma membrane even at a 267 
concentration ten times higher than its critical micellar concentration of 14 mM (Fig. 1B). On 268 
the opposite, bile salt derivatives and alkyl glycosides proved to be very potent detergents to 269 
extract selectively spiralin from plasma membranes. In particular, CHAPS and DOC 270 
solubilized spiralin with a high enrichment factor (2.0 and 1.8, respectively), and a low 271 
optimal concentration (60 and 50 mM, respectively). Detergent concentration has to be kept 272 
as low as possible during the purification procedure because it has to be removed in the last 273 
step of the purification. This is the reason why we chose not to use detergents that gave higher 274 
enrichment factor at higher optimal concentrations such as cholylsarcosine, for example.  275 
Consequently, we chose a sequential detergent extraction procedure as a first step for 276 
the purification of spiralin before chromatographic separation. S. melliferum membranes were 277 
first treated with 20 mM Sarkosyl which solubilized about 40% of proteins including very 278 
little amount of spiralin (ca. 8%) and the fraction insoluble in these conditions was 279 
subsequently treated with 50 mM CHAPS which permitted to obtain a solution which 280 
contains spiralin as a major protein (Fig. 2, lane1, 2, and 3). Using Sarkosyl allowed not only 281 
to shorten the step of removing extrinsic proteins, but also to operate at more moderate pH 282 
(pH 7.4 instead of 9.5) as reported before [20,33]. 283 
 284 
3.2. Purification of spiralin by cation-exchange HPLC (CE-HPLC) 285 
The amount of spiralin obtained by preparative ASE is limited to 1 mg per separation. 286 
Indeed, an increase of the column diameter aiming at increasing the loading capacity would 287 
result in an excessive temperature transverse gradient and a poorer resolution. We aimed at 288 
optimizing the spiralin purification protocol by using a final separation step offering a higher 289 
adaptability to large amounts of available starting material. Our choice fell on the technique 290 
of ion exchange HPLC.  291 
The theoretical titration curve of S. melliferum spiralin was used to define the best 292 
conditions for purification by ion exchange HPLC. Since this protein has a pI of 8.4, a cation-293 
exchange method would be more appropriate than the anion-exchange option. Furthermore, a 294 
pH of 4.5 appeared to be optimal since in these conditions, the protein would have a net 295 
charge ca. +15, in principle a good compromise for adsorption/desorption when using a strong 296 
cation exchanger.  297 
The elution profile of CE-HPLC showed that the major single peak was eluted at 0.2 M 298 
NaCl as expected (Fig. 3). The isolated major peak was analyzed by SDS-PAGE and provided 299 
a single band at the expected size for spiralin (28.7 kDa) (Fig. 2, lane4). It should be noted 300 
that the amount of spiralin in the HPLC peak is larger than suggested by its height because 301 
spiralin has a low molar extinction coefficient (e ≈ 6520 M-1 cm-1 at 280 nm) due to the lack 302 
of tryptophan in its amino acid sequence [12].  303 
The time of purification was shortened by choosing the chromatographic procedure 304 
instead of the agarose-suspension electrophoresis separation: 12h for the ASE vs. 90 min for 305 
the CE-HPLC. Moreover, the capacity of the CE-HPLC column allows recovering up to 6 mg 306 
of purified spiralin per chromatography starting from 50 mg of total spiroplasma membranes. 307 
The efficiency of the overall purification procedure was estimated to be around 60%. We also 308 
successfully used a low-pressure cation exchange chromatography system to purify even 309 
larger amounts of spiralin. This permitted to collect 14 mg of purified spiralin per purification 310 
starting from 50 mg of total spiroplasma membranes (data not shown). 311 
  312 
3.3. Spiralin detergent-free micelles 313 
 The final step of the purification procedure consisted in removing both NaCl and 314 
CHAPS from the mixed micelle solution obtained by CE-HPLC. This was achieved by 315 
controlled dialysis using the Lipoprep equipment. During detergent removal, spiralin 316 
molecules aggregated under the form of globular particles as shown by transmission electron 317 
microscopy (Fig. 4). The size distribution of these particles revealed that the supra-molecular 318 
structures had a mean diameter of 19 nm (n=1359, sd = 4.7 nm). Further analysis by SEC 319 
confirmed that the mean diameter was in the same range of magnitude, i.e. 17.0 nm (Fig. 5A). 320 
Spiralin was eluted together with thyroglobulin, which has a molecular mass of 669 kDa and a 321 
Stokes radius of 8.5 nm. The average mass of spiralin micelles ca. 700 kDa, was similar to the 322 
spiralin detergent-depleted micelles obtained when spiralin was purified by preparative 323 
agarose suspension electrophoresis and subsequent dialysis [17]. The elution fractions of SEC 324 
were analyzed by fused-rocket immunoelectrophoresis (Fig. 5B). This result proved that the 325 
purified protein was spiralin. This, as explained below, suggests that the protein kept its 326 
native structure during the SEC step. Consequently, what was measured here is indeed the 327 
size of spiralin micelles rather than aggregates of unfolded protein. 328 
 329 
3.4. Evidence for the native structure of purified spiralin 330 
 Far-UV circular dichroism spectra of spiralin detergent-depleted micelles and of 331 
spiralin solubilized with SDS are displayed in Fig. 6A. The spectrum of spiralin micelles is 332 
characteristic of a highly organized protein containing a high proportion of periodic secondary 333 
structures. Deconvolution of the spectra was realized using the CDPro package (Fig. 6B). 334 
Results obtained with the ContinLL method indicate that spiralin has about 32% of ß-sheet 335 
structures and 18% of a-helices consistently with previous observations [17]. Moreover 336 
spiralin has 22% of turns. The addition of the mild detergent CHAPS did not have any effect 337 
on the content of secondary structure in spiralin, supporting the idea that the improved 338 
purification procedures could keep the spiralin structure similar to its native structure. 339 
Strikingly, the spectrum of SDS-treated spiralin shows that the denatured protein has a high 340 
proportion of a-helical structures (36%) and a low ß-sheet content (9%), while the proportion 341 
of turns and other structures (including disordered structures) is the same in the native and the 342 
denatured protein. Helix formation in the presence of SDS can be attributed to the presence of 343 
amphiphilic helices in spiralin [37-39]. Primary structure analysis suggested that spiralin 344 
might contain amphiphilic a-helices that could be non-structured in the absence of a 345 
hydrophobic environment. This was confirmed experimentally for one a-helix [40,41]. Our 346 
preferred hypothesis is that spiralin possesses one or more amphipathic a-helices that have no 347 
structure in solution but become ordered in the presence of detergent or another hydrophobic 348 
environment. The impact of SDS on the secondary structures of spiralin is thus consistent 349 
with the previous results [37]. That this could reflect a physiological function of spiralin still 350 
remains to be determined. 351 
 Antigenicity of the purified spiralin was tested by crossed immunoelectrophoresis 352 
(CIE). Proteins from whole S. melliferum membranes or purified spiralin were loaded on 353 
separate gels (Fig 7). The second migration was performed in agarose gels containing 354 
antibodies directed against total membrane protein extracts of S. melliferum. Fig. 7A shows 355 
that spiralin is by far the most abundant membrane protein in S. melliferum membranes and 356 
that it keeps its antigenic properties after extraction by DOC. The high purity of spiralin after 357 
CE-HPLC is illustrated in Fig. 7B. No other protein than spiralin could be detected 358 
confirming the results obtained by SDS-PAGE. Moreover, the positive signal obtained by CIE 359 
suggests that the purified spiralin retained some original structural conformations during the 360 
whole purification processes. Indeed, in-gel immunoprecipitation is possible only if at least 361 
three distinct epitopes are available to react with antibodies [42]. It is thought that a vast 362 
majority of the epitopes on proteins are conformational epitopes [43,44]. Therefore, given the 363 
rather small size of spiralin, the existence of at least three different epitopes strongly suggests 364 
that the protein kept its native structure during the purification procedure. 365 
   366 
 367 
4. Conclusion 368 
Mollicutes include a high number of pathogens for humans, animals and plants [45]. 369 
Because many lipoproteins are involved in Mollicutes pathogenicity or virulence, it is 370 
essential to have these proteins in a purified native form for functional studies aiming at better 371 
understanding Mollicutes-hosts interactions. Currently, most functional studies are carried out 372 
using truncated forms of Mollicutes lipoproteins to evaluate their effect on host cells. For 373 
example, synthetic lipopeptides corresponding to the N-terminal moiety of native lipoproteins, 374 
such as MALP-2 and FSL-1 derived from lipoproteins produced in mycoplasmas infecting 375 
mammals, initiated the innate immune response in host cells [46,47]; the production of a 376 
recombinant protein corresponding to S. citri spiralin polypeptidic moiety (thus lacking the 377 
acylated part) allowed to uncover the role of this lipoprotein in recognition of host cell 378 
receptors [21]. The use of whole detergent extracts containing a mixture of lipoproteins in 379 
functional studies proved to be also useful in demonstrating the putative functional role of 380 
lipoproteins in the host immune response, as illustrated by the work on the human 381 
mycoplasma Mycoplasma hominis described in Truchetet et al. [48]. Now the availability of 382 
purified, complete lipoproteins in their native form could help validating the putative function 383 
in Mollicutes pathogenesis observed when using truncated lipoproteins. This should also 384 
enable us to gain more insights into the function of spiralin at the molecular level. Notably, 385 
protein-lipid interactions can now be tested in vitro in order to evaluate the importance of 386 
such interactions in living bacteria and in the context of the host-pathogen interactions. 387 
Moreover, the impact of spiralin on membrane shape and dynamics can be assessed using 388 
model systems such as liposomes. The data thus obtained should confirm or rule out the 389 
putative mechanical role of spiralin. We previously described a procedure for the purification 390 
of spiralin [10][17]. The previous purification process included the selective extraction of the 391 
protein by detergents from spiroplasma membranes, and a subsequent separation by agarose-392 
suspension electrophoresis. This previous strategy was used to purify spiralin and show its 393 
immunomodulatory function [16]. In this work, we found that Sarkosyl has a unique property 394 
of extracting large amounts of membrane proteins but not spiralin. This property was not 395 
obtained with any other detergents and suggests that spiralin is mostly insoluble in Sarkosyl. 396 
Moreover, replacing the ASE separation by a CE-HPLC step shortened drastically the time of 397 
the purification procedure. The amount of purified spiralin per round was increased from 1 398 
mg (ASE) to > 6 mg (CE-HPLC).  399 
This new purification procedure is based on the poor solubilization of spiralin by 400 
Sarkosyl, while this detergent could solubilize a large number of other membrane proteins. 401 
This peculiar behavior of spiralin during the extraction step could be due to specific spiralin-402 
lipid interactions. This assumption is based on the existence of preferred interactions of 403 
diverse acylated proteins with membrane parts enriched in specific lipids, such as sterols, 404 
sphingolipids -enriched membrane domains (rafts) in other biological membrane systems 405 
[49]. Following our purification process, both circular dichroism spectroscopy and crossed 406 
immunoelectrophoresis strongly suggested that spiralin kept a structure very close to its native 407 
structure. The high amount of protein that can be obtained by this new method opens the 408 
possibility for structural studies that are usually highly demanding in terms of protein 409 
material. We think that the whole strategy, based on a detergent screening for the double 410 
extraction step, will also prove to be useful for the purification of other lipoproteins, involved 411 
in Mollicutes pathogenesis and for which specific interactions with membrane lipids are 412 
suspected.  This should also open the way for the analysis of the three dimensional structure 413 
of lipoproteins, a procedure that usually requires high amounts of protein. Furthermore, this 414 
approach allows to obtain large quantities of proteins from the natural organism making 415 
possible the study of posttranslational modifications of surface proteins. The importance of 416 
such modifications, such as proteolysis, has been recently put forward and may play an 417 
important role in pathogenicity and increase the diversity of the cell surface proteome [50].  418 
 419 
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 569 
Figure captions 570 
Fig. 1. Examples of S. melliferum membrane protein extractions by detergents. Membranes 571 
were treated with cholylsarcosine (triangles), deoxycholate (circles), or Sarkosyl (squares) at 572 
various concentrations of detergents. Extracted proteins were separated from the insoluble 573 
material by centrifugation, and total proteins (A) and spiralin (B) were quantified in the 574 
solubilized fraction by densitometry analysis after SDS-PAGE. 575 
 576 
Fig. 2. Purity control of spiralin by SDS-PAGE. Lane 1, S. melliferum BC3 membrane 577 
proteins (10 µg) solubilized with 1% SDS; lanes 2 and 3, membrane proteins (2.5 µg) 578 
selectively extracted with 0.1 M CHAPS from membranes treated with 20 mM Sarkosyl; lane 579 
4, spiralin (2 µg) purified by cation-exchange HPLC; lane M, molecular weight markers. S 580 
indicates the migration of spiralin. All the samples contained 2 mM DTT. Protein bands were 581 
silver stained.  582 
 583 
Fig. 3. Chromatographic separation of spiralin. Spiralin purification by cation-exchange 584 
HPLC. Sample: 5 mg  of protein extracted with 0.1 M CHAPS in 4.2 ml of 20 mM sodium 585 
phosphate-citrate buffer (pH 4.5) containing 16 mM CHAPS and 2 mM DTT. Column: 586 
cation-exchange Protein Pack (Waters Millipore) SP8HR (Æ, 1 cm ; length, 10 cm). Flow 587 
rate: 1 ml min-1. Proteins were desorbed from the column using a 0 to 0.6 M NaCl linear 588 
gradient from fraction 20 to fraction 100. Elution of the was monitored by recording light 589 
absorption at 280 nm.           590 
 591 
Fig. 4. Analysis of spiralin detergent-free micelles by electron microscopy. Spiralin micelles 592 
were visualized by transmission electron microscopy after negative staining. Representative 593 
pictures (left) and the size distribution of the particles (right) are shown. The scale bar 594 
represents 200 mm. 595 
 596 
Fig. 5. Analysis of spiralin detergent-free micelles by size-exclusion chromatography (SEC). 597 
A. Spiralin micelles (dotted line) were eluted from a Superdex 200 HR 10/30 column with 50 598 
mM sodium phosphate pH 7.0 buffer containing 150 mM NaCl as the mobile phase (flow = 599 
0.4 ml min-1). Elution was followed by recording absorbance at 280 nm. Standard proteins 600 
(solid line) were: A, thyroglobulin; B, apoferritine; C, catalase; D, apotransferrin; E, 601 
ovalbumin; F, hemoglobin dimer; G, myoglobin; H, cytochrome c; I, vitamin B12. B. 602 
Fractions were collected after SEC and analyzed by fused-rocket immunoelectrophoresis. 603 
 604 
Fig. 6. Analysis of spiralin by circular dichroism spectroscopy. A. Circular dichroism spectra 605 
were obtained in the absence or presence of 50 mM CHAPS or 35 mM SDS in 10 mM 606 
phosphate buffer pH 7.4. Spiralin concentration was 3.8 µM. B. The relative abundance of 607 
secondary structures was measured using the CDPro package. 608 
 609 
Fig. 7. Antigenicity of spiralin. Proteins solubilized with DOC were analyzed by crossed 610 
immunoelectrophoresis in veronal buffer pH 8.6 containing 13 mM DOC. The samples were 611 
composed of 25 µg of S. melliferum membrane proteins (A) and 5 µg of pure spiralin (B). The 612 
immunoprecipitates were stained with Coomassie blue R250. S indicates the spiralin 613 
immunoprecipitation peak.  614 
 615 
 616 
Tables    617 
Table 1. Comparison of the efficacies of different detergents for the extraction of S. 618 
melliferum membrane proteins. 619 
 620 
Detergents Concopt (mM)a Protein yield (%)b Spiralin yield (%)c EFd 
 
Alkylated ionic detergents 
 
    
     DDMAB 100 86 70 0.8 
     DDMAU 25 90 65 0.7 
     Sarkosyl 50 55 15 0.3 
     SB-12 150 33 85 2.6 
     SB-14 
 
150 41 95 2.3 
Bile salts and derivatives 
 
    
     CHAPS 60 50 100 2.0 
     Cholic acid 100 50 90 1.8 
     Cholylsarcosine 150 38 100 2.6 
     DOC 50 55 100 1.8 
     Taurocholic acid 100 55 80 1.5 
     TauroDOC 
 
100 55 85 1.6 
Alkylglycosides 
 
    
     HECAMEG 60 35 100 2.8 
     NOGA 100 45 100 2.2 
     OG 
 
75 73 100 1.4 
POE detergents 
 
    
     Triton X-100 60 25 20 0.8 
          
(a) Lowest detergent concentration giving the highest yield of spiralin extraction. 621 
(b) Percentage of total membrane protein extracted. 622 
(c) Percentage of spiralin extracted. 623 
(d) Spiralin enrichment factor (EF= % spiralin yield / % total protein yield). The fraction 624 
solubilized with a given detergent is enriched with spiralin if EF > 1. EF = 4 is the 625 
maximum valuable that can be attained since spiralin represents 25% (by mass) of the 626 
total membrane protein. 627 
 628 
Figure 1
To
ta
l p
ro
te
in
 e
xt
ra
ct
io
n 
yi
el
d 
(%
)
Detergent concentration (mM)
Should appear in black and white in the online
and the print versions
single-column fitting figure
S
pi
ra
lin
 e
xt
ra
ct
io
n 
yi
el
d 
(%
)
Detergent concentration (mM)
A B
Cholylsarcosine
Deoxycholate
Sarkosyl
1 2 3 4 M
94
67
43
30
20
14.4
Figure 2
S
Should appear in black and white in the 
online and the print versions
single-column fitting figure
kDa
Figure 3
Fractions
N
aC
l (
M
)
A
28
0n
m
 (A
U
)
1 25 50 75 100
0
2.5
5
7.5
10
0
0.25
0.50
0.75
1.00
Should appear in black and white in the 
online and the print versions
single-column fitting figure
A B
Figure 4
P
er
ce
nt
ag
e 
of
 m
ic
el
le
s
Micelle diameter (nm)
Should appear in black and white in the online
and the print versions
2-column fitting figure
A
28
0n
m
Time
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34
A B C D E F
D
ire
ct
io
n 
of
 m
ig
ra
tio
n
Fractions from SEC
22
21
19
18
17
16
15
14
13
12
11
23
24
25
26
27
28
29
30
31
32
33
34
35
Fraction 22
A
B
Figure 5
Should appear in black and white in the online
and the print versions
1.5-column fitting figure
Figure 6
Should appear in color in the online version
and in black and white in the print version
single-column fitting figure
No detergent
50 mM CHAPS
35 mM SDS
Helices Sheets Turns Other
18 32
3123936
30223018
2822
B
A
AB
1st direction
1st direction
2n
d 
di
re
ct
io
n
2n
d 
di
re
ct
io
n
S
S
Figure 7
Should appear in black and white in the online
and the print versions
single-column fitting figure
